Among the 841 transplant patients who took GLP-1 drugs, 72% started them after their transplants. Median time to first GLP-1 ...

Joe Biden says he did not know he had cancer while he was president and would not have sought a second term if he already had ...

As the Centers for Medicare & Medicaid Services (CMS) doled out the final 200 of an additional 1,000 residency positions ...

The estimated 25-year cumulative incidence of combined death or MI in COURAGE was 93.3% with added PCI and a similar 91.0% ...

Risks of a primary safety outcome event -- bleeding, reoperation for wound problems, or myocardial infarction -- were 3.65% and 2.88% for warfarin versus aspirin; 3.70% and 3.02% for rivaroxaban ...

Preventing and screening for common cancers seen in the general population should be a key component of HIV care, experts ...

Google's artificial intelligence (AI) chatbot Gemini helped a 13-year-old girl prepare a suicide plan, according to a lawsuit ...

Survodutide, an investigational glucagon receptor and GLP-1 receptor dual agonist, was safe for patients with obesity and ...

Kennedy Jr. should be impeached by the House of Representatives and then removed by the Senate. Can this be done? Yes.

Understanding how HIV can shape cardiovascular disease risk may help clinicians tailor care to patients' needs, which starts ...

T-cells have emerged as a second- and later-line treatment strategy for patients with diffuse large B-cell lymphoma (DLBCL), with three FDA-approved products. "Across CAR T-cell products in patients ...